North America – Page 120 – pharmaceutical daily

February 23, 2017 Off

A survey finds constantly checking electronic devices linked to significant stress for most Americans

A decade after the emergence of smartphones, Facebook and Twitter, more than four out of five adults in the U.S. report that they constantly or often check their email, texts and social media accounts, according to part two of the American Psychological Association’s (APA) report Stress in America: Coping with Change. This attachment to devices and the constant use of technology is associated with higher stress levels for these Americans.

February 22, 2017 Off

PMV Pharmaceuticals bags $74M in series B financing round, and adds a new board member

By Dino Mustafić

PMV Pharmaceuticals, Inc., a cancer focused developer of p53-targeted small molecule drugs, has completed a Series B financing round bagging $74 million.

February 22, 2017 Off

BD in new performance standards to improve influenza testing quality

By Dino Mustafić

BD said on Wednesday that its BD Veritor System Flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new Food and Drug Administration’s (FDA’s) performance requirements.

February 22, 2017 Off

TopiVert’s gives dry eye syndrome candidate to first patient, waits results in second half of 2017

By Dino Mustafić

A UK-based private clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for the treatment of chronic inflammatory gastrointestinal (GI) and ocular diseases, has triggered the phase 1/2a proof of concept study in the US of TOP1630 ophthalmic solution for the treatment of the dry eye syndrome.

February 22, 2017 Off

Verona kicks off phase two for its COPD candidate RPL544 as add-on to Spiriva

By Dino Mustafić

Verona Pharma has made an important step in the phase two clinical trial for its candidate RPL554, used for chronic obstructive pulmonary disease (COPD). Namely, the first patient has been dosed testing RPL544 as an add-on therapy to tiotropium, Spiriva.

February 22, 2017 Off

Heal Your Heart: Can a Gift Help Prevent Heart Disease?

By Dino Mustafić

What does a healthy heart really mean? Is it just the physical heart muscle that matters, or is there an important emotional component?
And can the simple act of conveying your best wishes and intentions make a real difference in the health of the recipient’s heart — and even your own? What does the science say?

February 21, 2017 Off

BMS in $2 Billion accelerated share repurchase program, names 3 new directors

By Dino Mustafić

Bristol-Myers Squibb has entered into an ASR program with each of Morgan Stanley & Co. LLC and Goldman, Sachs & Co. to repurchase, in aggregate, $2 billion of Bristol-Myers Squibb’s common stock, and it has named three new directors.

February 21, 2017 Off

‘Fasting-mimicking’ diet said to reduce risk factors for aging

By Dino Mustafić

Following a diet that mimics fasting may reduce risk factors for disease in generally healthy people, according to a small study.

February 21, 2017 Off

Inova to use Omnicell’s Performance Center

By Dino Mustafić

Omnicell has bagged a deal with Inova, a not-for-profit healthcare system based in Northern Virginia, for its integrated software and services offering, Performance Center.

February 21, 2017 Off

The thirteenth director; American Brain Tumor Association gets 4 new board members

By Dino Mustafić

The American Brain Tumor Association (ABTA) has elected four new members to its Board of Directors in January, to bring the number of directors to thirteen.